ACE2 and Alzheimer disease: Since ACE2 is expressed in both glutamatergic and GABAergic neurons, SARS-CoV-2 infection could initiate and/or exacerbate an imbalance between excitatory and inhibitory neuronal circuits, leading to excitotoxicity and cell loss, which also occurs during AD progression [17].